Citation Impact
Citing Papers
PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS OF THERAPY OF EXPERIMENTAL ENDOCARDITIS
1993
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled Trial
2007
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Infective Endocarditis
2005 Standout
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
2012
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
2011
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses
1996
Donor–Acceptor Oligorotaxanes Made to Order
2011 StandoutNobel
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
2003
Cystic Fibrosis Pulmonary Guidelines
2009
A Meta-Analysis of the Relative Efficacy and Toxicity of Single Daily Dosing Versus Multiple Daily Dosing of Aminoglycosides
1997
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
The Impact of Penicillinase on Cefamandole Treatment and Prophylaxis of Experimental Endocarditis Due to Methicillin‐ResistantStaphylococcus aureus
1998
Cystic fibrosis
2016 Standout
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
Prosthetic-Joint Infections
2004 Standout
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
2001
The Role of Advanced Generation Macrolides in the Prophylaxis and Treatment of Mycobacterium avium Complex (MAC) Infections
1997
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
2003
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*
2009
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins
1995
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Melioidosis
2003 Standout
Optical control of antibacterial activity
2013 StandoutNobel
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Results of a Multicenter Trial Comparing Imipenem/Cilastatin to Tobramycin/Clindamycin for Intra-abdominal Infections
1990
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
2001
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
2010
Triazole Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase
2009
A Combination of Amoxicillin and Clavulanate Every 12 Hours vs Every 8 Hours for Treatment of Acute Bacterial Maxillary Sinusitis
1998
Management of meningitis due to antibiotic-resistant Acinetobacter species
2009
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
The Science of Antibiotic Discovery
2020 Standout
Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
1996
A Meta-Analysis of Extended-Interval Dosing Versus Multiple Daily Dosing of Aminoglycosides
1997
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci
2000
Application of fluoroquinolone pharmacodynamics
2000
Pharmacodynamics of tobramycin in patients with cystic fibrosis
2005
Antimicrobial Action and Pharmacokinetics/Pharmacodynamics: The Use of AUIC to Improve Efficacy and Avoid Resistance
1999
Pharmacodynamic Interactions of Antibiotics Alone and in Combination
1998
Pharmacokinetic‐pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis
2000
Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally
2007
Antimicrobial resistance issues of the future
1996
Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance
2005
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
2008
Pharmacodynamics of cefepime in patients with Gram-negative infections
2002
Combination Antibiotic Therapy for Infective Endocarditis
2003
Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both
1989
Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: A retrospective, nonrandomized, open-label, historical chart review
2007
The Art of Fusion: From Penams and Cephems to Penems
2003
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia*
2008
Principles of antibacterial dosing in continuous renal replacement therapy
2009
The post-antibiotic sub-MIC effect in vitro and in vivo
1993
Airway Mucus Function and Dysfunction
2010 Standout
Aminoglycosides: An Overview
2016
Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia*
2003
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Clinical Efficacy and Pharmacoeconomics of a Continuous‐Infusion Piperacillin‐Tazobactam Program in a Large Community Teaching Hospital
2002
The APACHE III Prognostic System
1991 Standout
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
2004
Pharmacokinetic issues for antibiotics in the critically ill patient
2009
Loading dose of vancomycin in critically ill patients: 15mg/kg is a better choice than 500mg
2006
Assessment and Management of Foot Disease in Patients with Diabetes
1994 Standout
Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy
2007
Infective endocarditis
2004 Standout
Pharmacokinetics and Safety of Tobramycin After Once-Daily Administration in Patients With Cystic Fibrosis
1997
Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia
2004
Kinetics of antibiotics in relation to effective and convenient outpatient parenteral therapy
1995
How antibiotics kill bacteria: from targets to networks
2010 Standout
Versatility of Aminoglycosides and Prospects for Their Future
2003
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials
2005
Ventilator-associated Pneumonia
2002 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Pharmacodynamics of Fluoroquinolones against Streptococcus pneumoniae in Patients with Community-Acquired Respiratory Tract Infections
2001
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin
2005
Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus
2009
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity againstPseudomonas aeruginosain Murine Thigh and Lung Infection Models
2009
In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin
1993
Real-Time Monitoring of Bacterial Infection In Vivo: Development of Bioluminescent Staphylococcal Foreign-Body and Deep-Thigh-Wound Mouse Infection Models
2003
Pharmacodynamics of Daptomycin in a Murine Thigh Model of Staphylococcus aureus Infection
2001
Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis
1999
In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model
2018
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges
1993
Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin
1992
Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis
1990
Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy
1999
Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections
1991
A Toll-Like Receptor 2-Responsive Lipid Effector Pathway Protects Mammals against Skin Infections with Gram-Positive Bacteria
2005 StandoutNobel
Palladium-Catalyzed Anti-Markovnikov Oxidation of Allylic Amides to Protected β-Amino Aldehydes
2014 StandoutNobel
Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model
1996
Is continuous infusion of β-lactam antibiotics worthwhile?—efficacy and pharmacokinetic considerations
1996
First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use
1991
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
1995
Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection
1994
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
β-Peptides: From Structure to Function
2001 Standout
In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis
2003
Poly(d ,l -Lactide-Coglycolide) Particles Containing Gentamicin: Pharmacokinetics and Pharmacodynamics inBrucella melitensis- Infected Mice
2007
Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration
2000
Comparison of the Pharmacodynamics of Meropenem in Patients with Ventilator-Associated Pneumonia following Administration by 3-Hour Infusion or Bolus Injection
2005
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Use of Pharmacodynamic Indices To Predict Efficacy of Combination Therapy In Vivo
1999
Interventions for enhancing medication adherence
2014 Standout
β‐Peptides: Synthesis by Arndt‐Eistert homologation with concomitant peptide coupling. Structure determination by NMR and CD spectroscopy and by X‐ray crystallography. Helical secondary structure of a β‐hexapeptide in solution and its stability towards pepsin
1996
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Dosing Adjustment of 10 Antimicrobials for Patients with Renal Impairment
1995
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation
1991
Polyoxometalates in Medicine
1998 Standout
Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of Infection
2001
Disulfonimide-Catalyzed Asymmetric Synthesis of β3-Amino Esters Directly from N-Boc-Amino Sulfones
2013 StandoutNobel
Therapeutic drug monitoring of antimicrobials
2011
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
2004
Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis
1992
Foldamers: A Manifesto
1998 Standout
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis
1993
Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease
1996
Yersinia pestis--etiologic agent of plague
1997 Standout
Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation
2004
In Vivo Pharmacodynamic Activities of Two Glycylcyclines (GAR-936 and WAY 152,288) against Various Gram-Positive and Gram-Negative Bacteria
2000
Levofloxacin 300 mg Once-daily Versus Levofloxacin 100 mg Three-times-daily in the Treatment of Respiratory Tract Infections in Elderly Patients
2003
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Factors Related to Errors in Medication Prescribing
1997 Standout
Lipid X protects mice against fatal Escherichia coli infection
1988
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
1996
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
In vivo verification of in vitro model of antibiotic treatment of device-related infection
1995
Setting and Revising Antibacterial Susceptibility Breakpoints
2007
Pharmacokinetics and Pharmacodynamics of Meropenem in Febrile Neutropenic Patients with Bacteremia
2004
Works of Steven C. Ebert being referenced
Evidence for a Slow Elimination Phase for Penicillin G
1988
Comparative Antibiotic Dose-Effect Relations at Several Dosing Intervals in Murine Pneumonitis and Thigh-Infection Models
1989
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
1991
Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against Gram-negative bacilli
1991
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
1988
Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis
1991
Continuous infusion of beta-lactam antibiotics
1992
Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design
1990
Protein Binding and Its Significance in Antibacterial Therapy
1989
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
1987
Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model
1991
Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models.
1990
Elimination and tissue distribution of the monosaccharide lipid A precursor, lipid X, in mice and sheep
1988
Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design
1990